<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-10-GAMRIF-WP6-GARDP</iati-identifier>
  <reporting-org ref="GB-GOV-10" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Global Antimicrobial Resistance Innovation Fund (GAMRIF) - New Antibiotic for Drug-Resistant Gonorrhoea with GARDP</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Projects funded through GAMRIF will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The Global Antibiotic Research &amp; Development Partnership (GARDP) is a non-profit product development partnership, hosted by the Drugs for Neglected Diseases Initiative (DNDi) and started in association with the World Health Organisation (WHO). It is a research and development initiative addressing global public health needs by developing, delivering and assuring sustainable access of new or improved antibiotic treatments. UK Department of Health and Social Care (DHSC) funding through the Global AMR Innovation Fund (GAMRIF) will support GARDP&#x2019;s programme on sexually transmitted infections (STI), specifically focusing on the development of a new antibiotic for drug-resistant gonorrhoea.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The aim of this project is to fund and support the development of new treatments that address the threat of drug-resistant gonnorrhea in low- and middle- income countries (LMICs). Objectives of the funded activity are to: - develop a new affordable treatment for gonnorhoea, that works on multi-drug resistant cases (trials completed and registration started by 2022) - support the integration of the new treatments into the current Sexually Transmitted Infection management framework by investigating possible antibiotic combinations by 2023</narrative>
  </description>
  <participating-org role="4" type="21">
   <narrative xml:lang="EN">Drugs for Neglected Diseases Initiative</narrative>
  </participating-org>
  <participating-org activity-id="GAMRIF-WP6-GARDP" ref="GB-GOV-10" role="1" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <participating-org ref="GB-GOV-10" role="2" type="10">
   <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2018-05-22" type="1"></activity-date>
  <activity-date iso-date="2018-05-22" type="2"></activity-date>
  <activity-date iso-date="2019-03-31" type="3"></activity-date>
  <activity-date iso-date="2019-03-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Department of Health and Social Care (DHSC)</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">The UK&apos;s Department of Health and Social Care (DHSC) helps people to live more independent, healthier lives for longer. Our official development assistance (ODA) funded programmes take this objective beyond the UK to address global health challenges for the benefit of people living in low- and middle-income countries (LMICs).</narrative>
   </department>
   <telephone>0207 210 4850</telephone>
   <mailing-address>
    <narrative xml:lang="EN">Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="13040" percentage="100" vocabulary="1"></sector>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2018-05-22"></period-start>
   <period-end iso-date="2018-06-30"></period-end>
   <value currency="GBP" value-date="2018-05-22">312786</value>
  </budget>
  <budget status="1" type="1">
   <period-start iso-date="2018-09-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="GBP" value-date="2018-09-01">687214</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-05-22"></transaction-date>
   <value currency="GBP" value-date="2018-05-22">1000000</value>
   <description>
    <narrative xml:lang="EN">GAMRIF-WP6-GARDP MoU Agreement</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-10-GAMRIF-WP6-GARDP" ref="GB-GOV-10" type="10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Drugs for Neglected Diseases Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-22"></transaction-date>
   <value currency="GBP" value-date="2019-11-22">1503218</value>
   <provider-org provider-activity-id="GB-GOV-10-GAMRIF-WP6-GARDP" ref="GB-GOV-10" type="10">
    <narrative xml:lang="EN">UK - Department of Health and Social Care (DHSC)</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Drugs for Neglected Diseases Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-06-28"></transaction-date>
   <value currency="GBP" value-date="2018-06-28">312786</value>
   <provider-org provider-activity-id="GAMRIF-WP6-GARDP" ref="GB-GOV-10" type="10"></provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Drugs for Neglected Diseases Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-14"></transaction-date>
   <value currency="GBP" value-date="2018-12-14">687214</value>
   <provider-org provider-activity-id="GAMRIF-WP6-GARDP" ref="GB-GOV-10" type="10"></provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Drugs for Neglected Diseases Initiative</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://aidstream.org/files/documents/GAMRIF_PBC-20190627030658.pdf">
   <title>
    <narrative xml:lang="EN">Global AMR Innovation Fund - Programme Business Case</narrative>
   </title>
   <description>
    <narrative xml:lang="EN"></narrative>
   </description>
   <category code="A02"></category>
   <category code="A03"></category>
   <category code="A05"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gardp.org/2018/news-resources/press-releases/gardp-efforts-drug-resistant-gonorrhoea-treatment-boost-from-ukgovernment/">
   <title>
    <narrative xml:lang="EN">Article: GARDP&#x2019;s efforts for drug-resistant gonorrhoea treatment receive boost from UK government</narrative>
   </title>
   <description>
    <narrative xml:lang="EN"></narrative>
   </description>
   <category code="A02"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-05-22"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gov.uk/government/news/30-million-of-funding-to-tackle-antimicrobial-resistance">
   <title>
    <narrative xml:lang="EN">Article: funding to tackle antimicrobial resistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN"></narrative>
   </description>
   <category code="A06"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-05-22"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://aidstream.org/files/documents/MOU_DHSC-and-DNDI_GAMRIF_PUBLISH-20190627010612.pdf">
   <title>
    <narrative xml:lang="EN">Global AMR Innovation Fund - MoU - DHSC and DNDI</narrative>
   </title>
   <description>
    <narrative xml:lang="EN"></narrative>
   </description>
   <category code="A04"></category>
   <category code="A11"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="GB-GOV-10-GAMRIF -BACTIVAC" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP1-UK-CHINA" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP2-CARBX" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP3-InnoVet-AMR" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP4-UK-Argentina" type="3"></related-activity>
  <related-activity ref="GB-GOV-10-GAMRIF-WP5-FIND" type="3"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Release of funding conditional on completion of reporting requirements as specified in MoU</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
